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OBJECTIVE: The prognosis of patients with biliary atresia undergoing Kasai portoenterostomy is related to the
timing of the diagnosis and the indication for the procedure. The purpose of the present study is to present a
practical flowchart based on 257 children who underwent Kasai portoenterostomy.
METHODS: We conducted a retrospective cohort study of patients who underwent Kasai portoenterostomy
between 1981 and 2016.
RESULTS: During the first period (1981 to 2009), 230 infants were treated, and the median age at the time of
surgery was 84 days; jaundice was resolved in 77 patients (33.5%). During the second period, from 2010 to 2016,
a new diagnostic approach was adopted to shorten the wait time for portoenterostomy; an ultrasonography
examination suggestive of the disease was followed by primary surgical exploration of the biliary tract without
complementary examination or liver biopsy. Once the diagnosis of biliary atresia was confirmed, a porto-
enterostomy was performed during the same surgery. During this period, 27 infants underwent operations; the
median age at the time of surgery was 66 days (po0.001), and jaundice was resolved in 15 patients (55.6% -
p=0.021), with a survival rate of the native liver of 66.7%.
CONCLUSION: Primary surgical exploration of the biliary tract without previous biopsy was effective at
improving the prognostic indicators of patients with biliary atresia undergoing Kasai portoenterostomy.
KEYWORDS: Biliary Atresia/Surgery; Hepatic Portoenterostomy; Survival Rate; Liver Transplantation; Neonatal
Jaundice.
’ INTRODUCTION
Biliary atresia (BA) is a rare disease of infancy, and patients
present with jaundice and pale stools in the first few weeks
of life. The etiopathogenesis of BA is not fully understood,
and the disease is likely the phenotypic manifestation of
various mechanisms that can act alone or jointly. Genetic
causes, exogenous agents (viruses and toxins), immunologi-
cal mechanisms and ductal plaque malformations have been
implicated in the development of this condition. If left untrea-
ted, BA rapidly evolves into liver failure secondary to biliary
cirrhosis, and the mean survival rate is less than 2 years (1,2).
Histologically, BA is characterized as an obliterative cholan-
giopathy. In most cases, it obliterates the luminal opening
of the most proximal part of the extrahepatic biliary tree.
Kasai portoenterostomy (KP), considered the standard sur-
gical treatment for this condition, restores bile flow to the
intestinal lumen through residual ductules in the porta hepatis
region that retain some connection to the potentially pre-
served intrahepatic biliary tree (3). Although KP is successful
in many infants, the procedure has a high failure rate. Some
patients receive no benefit from the procedure and even-
tually develop end-stage liver disease. For these patients, the
only option is liver transplantation (LT). In Brazil, BA is the
indication for approximately 60% of LTs (4,5). Our center
conducted the first pediatric LT in Brazil (1989), and more
than 700 procedures have been performed since.
In 1999, the first national survey on BA was conducted,
compiling 664 cases from 18 Brazilian institutions (non-
published data). The median age of the children who under-
went KP was 90 days, which is much older than that reported
in other centers worldwide (6-8). Since the survey was
conducted, an effort has been made by public health services
and physicians to more quickly refer suspected patients to
specialized centers, although at present, Brazil lacks the clear
and rigorous regionalization found in the UK (9) and other
countries. Aiming to shorten the time that patients wait for
a portoenterostomy, our hospital adopted a new diagnostic
approach for suspected cases of BA in 2010. In cases with a
high clinical index of suspicion (progressive cholestasis,DOI: 10.6061/clinics/2018/e289
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persistent acholic stools) supported by an ultrasonography
examination that excludes other possible surgical diagnoses
(e.g., choledochal malformation, inspissated bile syndrome,
bile duct perforation) and shows an atrophic gallbladder or the
triangular cord sign, we perform primary surgical exploration
of the bile ducts through a small right subcostal laparotomy
without previous complementary examinations or liver biopsy.
Once the diagnosis of BA is confirmed (occasionally with intra-
operative cholangiography), we extend the incision and perform
a portoenterostomy during the same surgery. The aim of this
study is to report the results of BA surgery performed between
1981 and 2016 (257 patients) at a Brazilian medical center and
to analyze the impact of primary surgical exploration with-
out previous liver biopsy on the clearance of jaundice.
Figure 1 - Perinatal cholestasis flowchart (TPN – total parenteral nutrition; KP – Kasai portoenterostomy).
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’ PATIENTS AND METHODS
The study was approved by the Ethics Committee for
Research Project Analysis at our institution. The records of
all consecutive patients undergoing Kasai surgery at our
institution between 1981 and 2009 were retrospectively rev-
iewed. From 2010 onward, a second group of consecutive
patients with suspected BA were managed according to a
new protocol aimed at shortening the wait time for porto-
enterostomy (Figure 1).
All patients were operated on by the same group of
surgeons at our institution. Infants underwent surgical
excision of the biliary remnant with resection extended to
the border of the portal vein bifurcation according to the
principles described by Kasai (3). Remnant excision was
followed by a 40-cm Roux-en-Y loop biliary reconstruction
(Figure 2). During the early period, 33 infants had an initial
but temporary stoma constructed in the Roux loop (Suruga II
modification). We did not adopt the laparoscopic approach
because there is no evidence to support its superiority or
even equivalence in the later results (10). The diagnosis of
BA was confirmed in all cases by histological analysis of
the liver and biliary remnants. We included the 257 patients
who underwent operations during the last 35 years (mean
of 7 cases/year) and received regular follow-up for at least
12 months in our care.
Postoperative care has evolved over time and has included
ursodeoxycholic acid and oral antibiotics since the 1990s.
Steroids (1 mg/kg/day prednisone for 4 weeks; therapy is
initiated after the postoperative fasting period, followed by a
4-week taper) have been used since 2007. All patients were
followed-up for a minimum of 12 months.
Comparisons of the data were performed with IBM SPSS
Statistics 17 (SPSS Inc. Released 2008. SPSS Statistics for
Windows, Version 17.0. Chicago, IL, USA: SPSS Inc.). We com-
pared the data from the two study periods to verify the effect
of the new diagnostic and therapeutic approach. Categorical
variables were compared by w2 tests. Native liver survival
was expressed as a Kaplan-Meier curve, with both LT and
death treated as events. p-values less than 0.05 were regarded
as significant.
’ RESULTS
The demographic data of patients are included in Table 1.
Among all BA patients, microscopic examination of the
transected bile duct remnant revealed 23.9% type I, 30.4%
type II and 45.7% type III portal plates. Eight patients
were identified as having an associated splenic malformation
(polysplenia with or without a preduodenal portal vein).
During the first period, 230 patients were treated. The
median age at KP was 84 days (11-188 days). Jaundice was
resolved in 77 patients (33.5%) within 3 months of porto-
enterostomy. During the second period, 27 infants with BA
underwent surgery. The median age at KP was 66 days
(28-103 days), and the mean body weight was 4.97±0.38 Kg,
both of which were significantly different from the previous
period (po0.001). Jaundice was resolved in 15 patients (55.6%)
during the second period, which was a significant increase
compared to the first period (w2=5.354; p=0.021).
Among the anicteric patients in the first period, 19 (24.7%)
later underwent LT (more than 2 years after KP) due to recurrent
cholangitis and a relapse of jaundice, hepatic dysfunction, uncon-
trollable portal hypertension or hepatopulmonary syndrome.
During the second period, among all KP patients, five (18.5%
of total) underwent LT, and four icteric patients died while
on the waiting list for LT due to sepsis or hemorrhage (due to
esophageal varices). Hepatopulmonary syndrome developed
in one jaundice-free child at one year after surgery. The
survival rate of the native liver in the second group was
higher than that in the first group (Figures 3 and 4). The
mean follow-up through the end of the study in this group
was 1903.2 days. Twenty-nine patients from the first period
and 2 patients from the second period were excluded due to
a lack of information during follow-up.
Exploration of the bile ducts without previous liver biopsy
followed by optional KP during the same surgery character-
ized the strategy used to manage patients who were treated
during the second period. Using this new protocol, 2 patients
underwent surgical exploration despite an intraoperative
finding of patent bile ducts. In each case, we performed a
liver biopsy. The histopathological diagnoses were neonatal
hepatitis in one case and ductopenia in the other.
’ DISCUSSION
Biliary atresia is a rare disease, with estimates of its pre-
valence ranging from 1 in 6,000 in Taiwan to 1 in 20,000 in
Northern Europe (8,11). Therefore, the current birth rate in
Brazil (approximately 3,000,000 annually for the last 5 years)
suggests that 150 to 300 infants with BA are born each year in
our country.
The currently accepted standard treatment for BA is a KP
performed at the earliest possible age by experienced surgeons.
LT is indicated for children in whom jaundice does not resolve
after KP and who therefore develop end-stage liver disease or
complications. Transplantation should be performed as timely
as possible to avoid death of patients on the waiting list.
Figure 2 - Final aspect of the surgery. Note the Roux-en-Y jejunal
loop draining the transected porta hepatis.
Table 1 - Demographic data of patients from the two study
groups.
1981 - 2009 2010 - 2016
Gender Male 90 (39.1%) 12 (44.4%)
Female 140 (60.9%) 15 (55.6%)
Weight kg (Mean±sd) 5.34±0.43 4.97±0.38*
*po0.001.
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Although variation has been observed in the postoperative
evolution in children after Kasai’s surgery (12), the median
time to KP is likely a relevant factor in the prognosis. This
analysis allows the inference of a population’s access to basic
health services and the diagnostic efficiency of each region.
In this cohort, we identified a significant evolution in our
institution over time, characterized by significant improve-
ment in surgical outcomes, particularly during the last decade.
Despite this success, a lack of investment in primary care,
poor resource management and great variability in access
to specialized resources represent substantial challenges
to our ability to care for these patients. Brazil is a country
of continental dimensions that does not yet have well-
structured regional or central medical systems.
To minimize the interval between diagnostic suspicion and
surgical treatment, we chose to dispense with the traditional
time-consuming complementary tests (endoscopic retrograde
cholangiopancreatography, radio-isotope-labeled hepatobili-
ary scans, and even percutaneous liver biopsy) in most cases
presenting with strong clinical/ultrasonographic evidence
of BA. We performed open surgical exploration of the biliary
tract with an optional intraoperative cholangiography when
BA type 1 or 2 was suspected. We believe that this protocol
should be generally adopted and that it can be a simple and
effective alternative that reduces the median time to KP,
especially in countries with geographic, demographic and
economic characteristics similar to Brazil.
In two cases, we performed a laparotomy even though BA
was not confirmed. In our view, no increase in morbidity
is caused by performing a small right subcostal laparotomy
with biopsy and cauterization of the liver capsule, which mini-
mizes the risk of bleeding. Another possible alternative was
initial laparoscopy for all patients, but since the defini-
tive treatment of confirmed BA cases would necessitate an
open incision, we did not adopt this strategy. Finally, it is
important to emphasize that although laparoscopic porto-
enterostomy represents a tempting procedure for the correc-
tion of BA, outcomes in terms of native liver survival rates and
actuarial survival rates are not superior to those of conven-
tional surgery by open laparotomy, as we propose herein.
There is no evidence showing that laparoscopic KP performed
prior to a subsequent LT is associated with fewer adhesions (10).
Figure 3 - Kaplan-Meier native liver survival curve (1981-2009 / n=230).
Figure 4 - Kaplan-Meier native liver survival curve (2010-2016 / n=27).
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Finally, our results suggest that laparoscopic KP may be
abandoned in pediatric surgery.
We were pleased to identify a dramatic improvement in
the percentage of jaundice clearance (55.6%) in recent years.
In addition, our recent actuarial native liver survival (66.7%)
and patient survival (77.8%) rates are comparable to those of
other large studies (12).
In conclusion, the current study shows that the measures
undertaken in recent years, including primary surgical explo-
ration of the bile tract without previous biopsy, have resulted
in significant improvements in two key indices commonly
used to characterize a BA program (median time to KP and
jaundice clearance).
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